由中央广播电视总台央广采制的广播特写《翁丁,一个云雾缭绕的山寨》获得2018年亚洲太平洋广播电视发展机构(Asia-Pacific Institute for Broadcasting Development,简称AIBD)奖的雷恩哈德·昆纳奖2018年度最佳广播节目奖。本文从...由中央广播电视总台央广采制的广播特写《翁丁,一个云雾缭绕的山寨》获得2018年亚洲太平洋广播电视发展机构(Asia-Pacific Institute for Broadcasting Development,简称AIBD)奖的雷恩哈德·昆纳奖2018年度最佳广播节目奖。本文从该作品的谋篇布局、主题挖掘、采访制作、音响运用等方面分享创作感悟。展开更多
To the Editor:Autoimmune bullous diseases(AIBDs)are a diverse group of autoimmune disorders affecting the skin and mucous membranes,characterized by vesicles,blisters,and erosions due to autoantibodies targeting struc...To the Editor:Autoimmune bullous diseases(AIBDs)are a diverse group of autoimmune disorders affecting the skin and mucous membranes,characterized by vesicles,blisters,and erosions due to autoantibodies targeting structural proteins.AIBDs are mainly categorized into pemphigus,[1]with antibodies against epidermal cell surface proteins,and pemphigoid diseases,[2]targeting proteins in the epidermal basement membrane.[3]Pemphigus vulgaris(PV)is the most common intraepidermal AIBD and typically affects individuals aged 40–60 years,while bullous pemphigoid(BP)is the leading subepidermal AIBD,with incidence increasing among older populations.Given the variety of available topical and systemic treatments,it is vital to evaluate their effectiveness and safety.However,there is a lack of knowledge regarding the comparative effectiveness of these therapies.Our objective is to synthesize existing evidence on AIBD management through direct comparisons and generate treatment rankings using network meta-analysis(NMA)to inform clinical decision-making and optimize therapeutic strategies.展开更多
文摘由中央广播电视总台央广采制的广播特写《翁丁,一个云雾缭绕的山寨》获得2018年亚洲太平洋广播电视发展机构(Asia-Pacific Institute for Broadcasting Development,简称AIBD)奖的雷恩哈德·昆纳奖2018年度最佳广播节目奖。本文从该作品的谋篇布局、主题挖掘、采访制作、音响运用等方面分享创作感悟。
基金supported by a grant from the National Natural Science Foundation of China(No.82003347).
文摘To the Editor:Autoimmune bullous diseases(AIBDs)are a diverse group of autoimmune disorders affecting the skin and mucous membranes,characterized by vesicles,blisters,and erosions due to autoantibodies targeting structural proteins.AIBDs are mainly categorized into pemphigus,[1]with antibodies against epidermal cell surface proteins,and pemphigoid diseases,[2]targeting proteins in the epidermal basement membrane.[3]Pemphigus vulgaris(PV)is the most common intraepidermal AIBD and typically affects individuals aged 40–60 years,while bullous pemphigoid(BP)is the leading subepidermal AIBD,with incidence increasing among older populations.Given the variety of available topical and systemic treatments,it is vital to evaluate their effectiveness and safety.However,there is a lack of knowledge regarding the comparative effectiveness of these therapies.Our objective is to synthesize existing evidence on AIBD management through direct comparisons and generate treatment rankings using network meta-analysis(NMA)to inform clinical decision-making and optimize therapeutic strategies.
